-
A New Issue Flares in the 2024 Race: Campus Protests
With tensions escalating and Republicans pouncing, President Biden finally weighed in and sought to increase the distance between himself and some of the more radical activism on colleges.
-
Weapons in U.S. Aid Bill Can’t Come Fast Enough for Ukraine
President Biden and Ukraine’s allies have invoked a sense of urgency over weapon deliveries. But there are logistical hurdles, and Ukraine has little time to lose.
-
The Art of Balancing Work and Play: Tips from Successful Entrepreneurs
In today’s fast-paced and competitive work environment, it can be challenging to find a balance between work and play. With the constant pressure to achieve success and meet deadlines, many people often neglect their personal lives and hobbies. However, successful entrepreneurs understand the importance of maintaining a healthy balance between work and play. They know…
-
[Audio] Episode 89: Tamás Fehér | Jalsovszky Law Firm
Tamás Fehér is a partner with Jalsovszky Law Firm, the Hungarian member of the International Lawyers Network, where he practices tax litigation. In this episode, Lindsay and Tamás discuss the challenges and opportunities of AI and technology, how he came to practice both tax and litigation and the unique issues that non-native English-speaking countries face…
-
In This Month’s E-News: May 2024
Some funding applications submitted to NIH beginning Jan. 25 will face new requirements and undergo a revised peer review process. To prepare investigators and institutions, NIH launched a dedicated website with details about specific changes and recently issued what Mike Lauer, NIH director of extramural research, called an “uber notice.” Lauer discussed the changes in…
-
OHRP FY 25 Budget Request Lacks Prior Plea For Funding, Staff Increases; Plans Are Modest
In December 2022, Julie Kaneshiro—then deputy director of the HHS Office for Human Research Protections (OHRP)—disclosed that the agency had 32 positions but that only 20 were filled, leaving 12 vacant or “on hold,” due to “resource constraints.” But OHRP’s budget justification documents for fiscal year (FY) 2025—which begins Oct. 1—propose little additional funding and…
-
FTC Weighs In on Orange Book Listing of Drug-Device Patents
On March 22, 2024, the Federal Trade Commission (“FTC”) filed an amicus brief in Teva Branded Pharmaceutical Products R&D, et al. v. Amneal Pharmaceuticals of New York, LLC, et al., 2:23-cv-20964, U.S. District Court for the District of New Jersey (“Teva v. Amneal”), stating that the court should grant Amneal’s motion for judgment on the…
-
Does the EU AI Act Classify Your AI System as High Risk?
Now that the European Parliament has approved the EU AI Act, you should understand how the broad AI regulation affects your business….By: Goodwin
-
Case “Runners” Are Back Because They Never Left . . . And Are Battling It Out in Court
We have all heard the terms “ambulance chasers” or “case runners” used to describe unethical practices of personal injury law firms. Even the general public is familiar with these terms, mostly from the use of them in comedy sketches or bad “dad” jokes. It seems that something that we have known to be true, but…